AFG
RPRX icon

Atomi Financial Group’s Royalty Pharma RPRX Stock Holding History

Atomi Financial Group’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$717K Buy
12,784
+1,338
+12% +$69.6K 0.02% 619
2026
Q1 		$549K Buy
11,446
+828
+8% +$36.3K 0.02% 683
2025
Q4 		$410K Buy
10,618
+1,896
+22% +$72.3K 0.01% 784
2025
Q3 		$308K Buy
8,722
+674
+8% +$24.4K 0.01% 875
2025
Q2 		$290K Buy
8,048
+210
+3% +$6.96K 0.01% 838
2025
Q1 		$244K Buy
+7,838
New +$248K 0.01% 876

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Atomi Financial Group's RPRX Position: Q2 2026 in Review

Atomi Financial Group increased its Royalty Pharma (RPRX) stake by 12% in Q2 2026, buying an estimated $69.6K and bringing the position to 12,784 shares worth $717K. The position accounts for 0.02% of the portfolio, ranked #619.

Atomi Financial Group first reported a position in RPRX in Q1 2025 and has held it in 6 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Atomi Financial Group held 12,784 shares of Royalty Pharma worth $717K as of Q2 2026.
  • Atomi Financial Group bought 1,338 Royalty Pharma shares in Q2 2026, an estimated $69.6K.
  • Royalty Pharma made up 0.02% of Atomi Financial Group's portfolio in Q2 2026, its #619 holding.
  • Atomi Financial Group first reported a position in Royalty Pharma in Q1 2025 and has held it in 6 quarters since.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.